Navigation Links
Janssen Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
Date:2/5/2013

TITUSVILLE, N.J., Feb. 5, 2013 /PRNewswire/ -- Janssen Research & Development, LLC, ("Janssen") announced today the publication of a new article that addresses integrated approaches to healthcare solutions. The authors challenge the healthcare industry to expand its thinking beyond product-focused, "magic bullet" drug development and discuss the need for an integrated approach to patient care, including use of devices, tools and services to help a patient's progress. The commentary, "Beyond magic bullets: true innovation in health care," was published in the February 2013 issue of Nature Reviews Drug Discovery and is available at: http://www.nature.com/nrd/journal/v12/n2/full/nrd3944.html.

"We are in the middle of a revolution for molecular medicine. Advances in the field are constantly yielding new information about the body and its diseases. The need to differentiate from existing therapies and the mandate for innovation are clear," said Husseini K. Manji , M.D., Global Therapeutic Area Head for Neuroscience, Janssen Research & Development, LLC, and senior author of the article. "Scientists and business leaders are looking for and implementing new strategies to bring forth innovative therapeutic approaches that are meaningful and measurable to patients, caregivers and payers."

The authors discuss solutions for central nervous system (CNS) disorders – a group of diseases and illnesses identified as one of the biggest challenges to our healthcare and economic environment. The predicted cost of these disorders to society worldwide is higher than that of cancer, diabetes and chronic respiratory diseases combined,[1] and many serious mental illnesses, for example, can affect a patient's ability to take medicines on a regular basis and become engaged in a treatment plan. The authors sugge
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
3. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
4. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
5. West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
6. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
7. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
8. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
11. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ANGELES , Sept. 30, 2014 ... biopharmaceutical research and development company specializing in oncology, ... 2b clinical trial evaluating aldoxorubicin compared to topotecan ... (SCLC) who have relapsed or were refractory to ... the widely-used chemotherapeutic agent, doxorubicin. CytRx has received ...
(Date:9/29/2014)... et SAN DIEGO ... Company, Ltd. (ci-après désignée Daiichi Sankyo) (TSE : 4568) ... aujourd,hui la conclusion d,un accord de fusion définitif ... la totalité des actions ordinaires en circulation d,Ambit ... par le biais d,une offre publique d,achat qui ...
(Date:9/29/2014)... Sept. 29, 2014  Bob Pack, who lost his ... on the California Medical Association to immediately cease airing ... the San Jose Mercury News called "shamelessly deceptive" and ... wants voters to believe about the measure is wrong." ... Prop 46 requirement that doctors check California,s ...
Breaking Medicine Technology:CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 2CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 4CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5
(Date:9/30/2014)... 30, 2014 Youth Town’s annual BBQ/Music ... a.m. to 2 p.m. at the Youth Town campus ... World sponsors this family-oriented festival, which will offer music, ... will feature a car show, arts and crafts fair, ... children’s games. Also, Lightning McQueen and Mater from the ...
(Date:9/30/2014)... 30, 2014 Signet Puerto Rico, ... in San Juan, Puerto Rico, leverages RamSoft’s PowerServer ... , Nivia Souffront, site Administrator for Signet Puerto ... are excited to bring in PowerServer RIS/PACS/PM because ... care and physician satisfaction while reducing our costs ...
(Date:9/30/2014)... 30, 2014 Named a ‘Post ... Longmeadow facility has officially announced that they will ... that combines advanced medical technology with supportive, personalized ... of the only non-hospital options available in the ... The primary focus of this Ventilator Program is ...
(Date:9/30/2014)... 2014 Seniors Guide will take part ... race beginning in Raleigh, to support Alzheimer’s North Carolina ... and care. , Associate Publisher of Seniors Guide Magazine, ... senior resource for the Raleigh-Durham-Chapel Hill areas of North ... will be helping their team, “Eye of the Tiger”, ...
(Date:9/30/2014)... Employment website iHire ( http://www.ihire.com ) ... its marketing group, adding an experienced professional to ... their hiring needs within all of iHire’s niche ... sales and business development roles in traditional, digital, ... advertising. , With a wide-ranging career that has ...
Breaking Medicine News(10 mins):Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 3Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 2Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 3Health News:iHire Expands Team With New Business Development Director 2
... Many of ... water scarcity have steep energy costs. , ... (PRWEB) June 17, 2010 -- This June award winning publication, IEEE Spectrum features ... water. According to a new special report in IEEE Spectrum magazine, the flagship monthly publication ...
... ... announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives S. ... ... the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives S. de ...
... is a great deal of interest in factors that contribute ... One factor that appears to contribute to the heritable ... codes for the serotonin transporter, also known as the serotonin ... transporter gene appears to increase one,s risk for depression and ...
... BOSTON (June 17, 2010) - Staying in shape may ... those with higher than desirable body fat percentages. In ... Nutrition Science and Policy at Tufts University found an ... metabolic risk factors that are precursors to cardiovascular disease ...
... ... like driving, especially those parents who live in areas where public transportation is limited or ... group in Walnut Creek and San Francisco to cope with this and many other dilemmas. ... Walnut Creek, CA (PRWEB) ...
... cancer treatment more likely to have variant, study shows ... identified a gene mutation that increases the risk of ... after surgery for early-stage breast cancer. , Tamoxifen is ... but previous studies have shown that it increases the ...
Cached Medicine News:Health News:Green Energy May Drain Our Water Supplies 2Health News:Green Energy May Drain Our Water Supplies 3Health News:Ellsworth Adhesives Announces New International Engineered Sales Representative 2Health News:PTSD: The serotonin system influences vulnerability and treatment 2Health News:Physical fitness may help reduce chronic disease risk in college students 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 3Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 4Health News:Gene Mutation Offers Clues to Tamoxifen-Blood Clot Link 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: